SCHEMBL7647577

SCHEMBL7647577

O=C(NC1CCC1)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.68

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.63
RAB9A P51151 4/20 0.63
HDAC4 P56524 3/20 0.59
HDAC6 Q9UBN7 1/20 0.59
SMN1; SMN2 Q16637 3/20 0.58
CYP1A2 P05177 1/20 0.58
HPGD P15428 1/20 0.58
CYP2C19 P33261 1/20 0.58
TRPV1 Q8NER1 5/20 0.56
SLC6A5 Q9Y345 1/20 0.53
KMT2A Q03164 3/20 0.53
MEN1 O00255 2/20 0.51
LMNA P02545 1/20 0.51
HTT P42858 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7652620 0.97 NPC1 (0.68) NPC1RAB9AHDAC4HDAC6SMN1; SMN2
SCHEMBL7647671 0.93 RAB9A (0.59) NPC1RAB9AHDAC4SMN1; SMN2CYP1A2
SCHEMBL6785503 0.85 HDAC4 (0.62) NPC1RAB9AHDAC4HDAC6TRPV1
SCHEMBL17927246 0.84 HDAC4 (0.65) NPC1RAB9AHDAC4
SCHEMBL123652 0.83 NPC1 (0.79) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL10210759 0.81 CHRNB2 (0.66) HDAC4HDAC6SLC6A5KMT2AMEN1
SCHEMBL520877 0.81 NPC1 (0.82) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL28928584 0.81 NPC1 (0.82) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL126657 0.81 NPC1 (0.82) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL8315644 0.80 HDAC4 (0.47) NPC1RAB9AHDAC4HDAC6SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6486349-B1 Amide therapeutics and methods for treating inflammatory bowel disease CENTAUR PHARMACEUTICALS, INC. 2002-11-26 US claimed
US-6486349-B1 Amide therapeutics and methods for treating inflammatory bowel disease CENTAUR PHARMACEUTICALS, INC. 2002-11-26 US disclosed